Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.33
- Piotroski Score 8.00
- Grade Neutral
- Symbol (NAVI)
- Company Navient Corporation
- Price $15.63
- Changes Percentage (-1.2%)
- Change -$0.19
- Day Low $15.41
- Day High $15.80
- Year High $19.68
Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through three segments: Federal Education Loans, Consumer Lending, and Business Processing. The company owns Federal Family Education Loan Program (FFELP) loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, as well as asset recovery services on FFELP loans owned by other institutions. It also owns, originates, acquires, and services refinance and in-school private education loans; and offers healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, consulting engagement, and public health programs, as well as business processing services to state governments, agencies, court systems, municipalities, and parking and tolling authorities. In addition, the company provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, other healthcare providers, and public health departments; and corporate liquidity portfolio services. Navient Corporation was founded in 1973 and is headquartered in Wilmington, Delaware.
- Last Earnings 08/14/2024
- Ex-Dividend for 5/16 Dividend 09/06/2024
- Dividend Payable 09/20/2024
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $16.50
- High Stock Price Target $17.00
- Low Stock Price Target $16.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.63
- Trailing P/E Ratio 8.83
- Forward P/E Ratio 8.83
- P/E Growth 8.83
- Net Income $228.00 M
Income Statement
Quarterly
Annual
Latest News of NAVI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
How long does COVID live on surfaces? Experts answer your coronavirus FAQs.
The new COVID-19 strains XEC and MV-1 are rapidly spreading worldwide. XEC, a variant of Omicron, is expected to become dominant. Transmission occurs mainly through respiratory particles, and preventi...
By USA Today | 1 day ago -
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ...
The CEO discusses the Lindy Biosciences opportunity, new wins, and sales team size. The CFO addresses margins and growth strategies. The CEO also mentions development programs and potential reactivati...
By Yahoo! Finance | 1 day ago -
Intel Corporation (INTC) Navigates Qualcomm Acquisition Rumors and Antitrust Concerns While Securing Multi-Billion Dollar Deal with AWS for Custom Xeon Chips
Goldman Sachs identifies Intel Corporation among the top AI superstars. Tech stocks' strong performance driven by AI is not a financial bubble. Historical trends show market consolidation after intens...
By Yahoo! Finance | 2 days ago
